9 February 2018
Assura plc
("the Company")
Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")
The Company announces that the following named PDMR was today granted the following share awards over ordinary shares of 10 pence each in the Company under the Company's Performance Share Plan ("PSP").
PDMR |
Position |
Number of Share Awards Granted |
Jayne Cottam |
CFO |
230,967 |
These awards are subject to two performance conditions which will be determined after the 2019/20 financial year. 50% of the award shares are subject to an absolute Total Shareholder Return ("TSR") performance condition, and the remaining 50% of the award shares are subject to an absolute Net Asset Value per share growth ("NAV") performance condition. Details of the TSR and NAV performance conditions are set out in the Company's Directors' Remuneration Report for 2015/16.
The Notification of Dealing Form for the PDMR can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Notification of dealing form
1 |
Details of the person discharging managerial responsibilities/person closely associated
|
|||||||
a) |
Name
|
Jayne Cottam |
||||||
2 |
Reason for the notification
|
|||||||
a) |
Position/status
|
CFO |
||||||
b) |
Initial notification/ Amendment
|
Initial notification |
||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||||
a) |
Name
|
Assura plc |
||||||
b) |
LEI
|
21380026T19N2Y52XF72 |
||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Share options over ordinary shares of 10 pence each
GB00BVGBWW93 |
||||||
b) |
Nature of the transaction
|
Grant of options under the PSP
|
||||||
c) |
Price(s) and volume(s)
|
|
||||||
d) |
Aggregated information
- Aggregated volume
- Price
|
|
||||||
e) |
Date of the transaction
|
9 February 2018 |
||||||
f) |
Place of the transaction
|
XLON |
Notes to Editors
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 30 September 2017, Assura's property portfolio was valued at £1,560 million.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association